161 related articles for article (PubMed ID: 30906710)
1. Immunohistochemical Assessment of BAP1 Protein in Mucoepidermoid Carcinomas.
Kakkar A; Guleria P; Madan K; Kumar R; Kumar S; Jain D
Indian J Otolaryngol Head Neck Surg; 2019 Mar; 71(1):33-37. PubMed ID: 30906710
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic profiling of salivary mucoepidermoid carcinomas reveals frequent BAP1, PIK3CA, and other actionable genomic alterations.
Wang K; McDermott JD; Schrock AB; Elvin JA; Gay L; Karam SD; Raben D; Somerset H; Ali SM; Ross JS; Bowles DW
Ann Oncol; 2017 Apr; 28(4):748-753. PubMed ID: 28327999
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen expression in mucoepidermoid carcinoma of salivary glands.
Cardoso WP; Denardin OV; Rapoport A; Araújo VC; Carvalho MB
Sao Paulo Med J; 2000 May; 118(3):69-74. PubMed ID: 10810331
[TBL] [Abstract][Full Text] [Related]
4. Oncocytic mucoepidermoid carcinoma of the salivary glands.
Jahan-Parwar B; Huberman RM; Donovan DT; Schwartz MR; Ostrowski ML
Am J Surg Pathol; 1999 May; 23(5):523-9. PubMed ID: 10328083
[TBL] [Abstract][Full Text] [Related]
5. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours.
Alves FA; Pires FR; De Almeida OP; Lopes MA; Kowalski LP
Int J Oral Maxillofac Surg; 2004 Sep; 33(6):593-7. PubMed ID: 15308260
[TBL] [Abstract][Full Text] [Related]
6. Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases.
Capodiferro S; Ingravallo G; Limongelli L; Mastropasqua MG; Tempesta A; Favia G; Maiorano E
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32325647
[TBL] [Abstract][Full Text] [Related]
7. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
Press MF; Pike MC; Hung G; Zhou JY; Ma Y; George J; Dietz-Band J; James W; Slamon DJ; Batsakis JG
Cancer Res; 1994 Nov; 54(21):5675-82. PubMed ID: 7522962
[TBL] [Abstract][Full Text] [Related]
8. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria.
Goode RK; Auclair PL; Ellis GL
Cancer; 1998 Apr; 82(7):1217-24. PubMed ID: 9529011
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of NUMB immunoreactivity in salivary gland carcinomas.
Maiorano E; Favia G; Pece S; Resta L; Maisonneuve P; Di Fiore PP; Capodiferro S; Urbani U; Viale G
Int J Immunopathol Pharmacol; 2007; 20(4):779-89. PubMed ID: 18179751
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of glutathione S-transferases, DT-diaphorase and an apparently tumour-specific cytosolic class-3 aldehyde dehydrogenase by Warthin tumours and mucoepidermoid carcinomas of the human parotid gland.
Sreerama L; Sladek NE
Arch Oral Biol; 1996 Jun; 41(6):597-605. PubMed ID: 8937651
[TBL] [Abstract][Full Text] [Related]
11. Salivary gland-like tumors of the breast express basal-type immunohistochemical markers.
Reyes C; Jorda M; Gomez-Fernández C
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):283-6. PubMed ID: 22935826
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis value of TTF-1, Napsin A and Ki-67 index in primary salivary gland-type lung carcinomas].
Zhang B; Lin J; Da J
Zhonghua Bing Li Xue Za Zhi; 2015 Jul; 44(7):499-503. PubMed ID: 26705042
[TBL] [Abstract][Full Text] [Related]
13. Primary mucoepidermoid carcinoma of the breast: a case report with immunohistochemical analysis and comparison with salivary gland mucoepidermoid carcinomas.
Palermo MH; Pinto MB; Zanetti JS; Ribeiro-Silva A
Pol J Pathol; 2013 Oct; 64(3):210-5. PubMed ID: 24166608
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma.
Hung YP; Jo VY; Hornick JL
Histopathology; 2019 Jul; 75(1):54-62. PubMed ID: 30801752
[TBL] [Abstract][Full Text] [Related]
15. Expression of membrane-bound mucins (MUC1 and MUC4) and secreted mucins (MUC2, MUC5AC, MUC5B, MUC6 and MUC7) in mucoepidermoid carcinomas of salivary glands.
Alos L; Lujan B; Castillo M; Nadal A; Carreras M; Caballero M; de Bolos C; Cardesa A
Am J Surg Pathol; 2005 Jun; 29(6):806-13. PubMed ID: 15897748
[TBL] [Abstract][Full Text] [Related]
16. Expression of cell adhesion molecule CD44 in mucoepidermoid carcinoma and its association with the tumor behavior.
Binmadi N; Elsissi A; Elsissi N
Head Face Med; 2016 Jan; 12():8. PubMed ID: 26821610
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated glycoprotein 72 (TAG-72) expression in salivary gland neoplasia: an immunohistochemical study using the monoclonal antibody (MAb) CC49.
Epivatianos A; Poulopoulos A; Kayavis I; Papanayotou P
Oral Dis; 2000 Mar; 6(2):112-7. PubMed ID: 10702789
[TBL] [Abstract][Full Text] [Related]
18. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in situ hybridization for detection of MAML2 rearrangements in oncocytic mucoepidermoid carcinomas: utility as a diagnostic test.
García JJ; Hunt JL; Weinreb I; McHugh JB; Barnes EL; Cieply K; Dacic S; Seethala RR
Hum Pathol; 2011 Dec; 42(12):2001-9. PubMed ID: 21777943
[TBL] [Abstract][Full Text] [Related]
20. Parotid gland mucoepidermoid carcinoma in a 4-year-old child.
Clarós P; Dominte G; Clarós A; Castillo M; Cardesa A; Clarós A
Int J Pediatr Otorhinolaryngol; 2002 Mar; 63(1):67-72. PubMed ID: 11879932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
